$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Insulin Pumps - Medical Devices Pipeline Assessment, 2016
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 09 May 2016 | 26503 | In Stock
Related Topics: Medical , Medical Devices

Introduction

Insulin Pumps - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Insulin Pumps - Medical Devices Pipeline Assessment, 2016" provides an overview of Insulin Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Insulin Pumps under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Insulin Pumps under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
for Insulin Pumps - Medical Devices Pipeline Assessment, 2016

  • 1 Table of Contents

    1 Table of Contents 2

    1.1 List of Tables 5

    1.2 List of Figures 7

    2 Introduction 8

    2.1 Insulin Pumps Overview 8

    3 Products under Development 9

    3.1 Insulin Pumps - Pipeline Products by Stage of Development 9

    3.2 Insulin Pumps - Pipeline Products by Segment 10

    3.3 Insulin Pumps - Pipeline Products by Territory 11

    3.4 Insulin Pumps - Pipeline Products by Regulatory Path 12

    3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date 13

    3.6 Insulin Pumps - Ongoing Clinical Trials 14

    4 Insulin Pumps - Pipeline Products under Development by Companies 15

    4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development 15

    4.2 Insulin Pumps - Pipeline Products by Stage of Development 16

    5 Insulin Pumps Companies and Product Overview 17

    5.1 Amrita Vishwa Vidyapeetham Company Overview 17

    5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17

    5.2 Andain, Inc Company Overview 19

    5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 19

    5.3 Cellnovo Ltd. Company Overview 21

    5.3.1 Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21

    5.4 CeQur SA Company Overview 25

    5.4.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 25

    5.5 ConvaTec Healthcare B S.a.r.l. Company Overview 27

    5.5.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 27

    5.6 Debiotech S.A. Company Overview 28

    5.6.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 28

    5.7 Hospira, Inc. Company Overview 31

    5.7.1 Hospira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

    5.8 Insulet Corporation Company Overview 33

    5.8.1 Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 33

    5.9 InsuLine Medical Ltd. Company Overview 36

    5.9.1 InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36

    5.10 LifeScan, Inc. Company Overview 40

    5.10.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

    5.11 MedSolve Technologies, Inc. Company Overview 42

    5.11.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

    5.12 Medtronic plc Company Overview 43

    5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43

    5.13 MicroPort Scientific Corporation Company Overview 47

    5.13.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47

    5.14 NanoMed Ltd Company Overview 50

    5.14.1 NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

    5.15 Phluid Corporation Company Overview 51

    5.15.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 51

    5.16 Sensile Medical AG Company Overview 52

    5.16.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 52

    5.17 SFC Fluidics LLC Company Overview 55

    5.17.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 55

    5.18 Spring Health Solutions Ltd. Company Overview 56

    5.18.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56

    5.19 Tandem Diabetes Care, Inc. Company Overview 57

    5.19.1 Tandem Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

    5.20 ViCentra B.V. Company Overview 59

    5.20.1 ViCentra B.V. Pipeline Products & Ongoing Clinical Trials Overview 59

    5.21 Ypsomed Holding AG Company Overview 60

    5.21.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 60

    6 Insulin Pumps- Recent Developments 63

    6.1 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 63

    6.2 Apr 28, 2016: Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance 65

    6.3 Apr 13, 2016: New Data Shows Benefits of Medtronic Insulin Pumps for People with Type 2 Diabetes 66

    6.4 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 67

    6.5 Mar 17, 2016: Medtronic Proposes Proxy Access 67

    6.6 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 67

    6.7 Mar 14, 2016: Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board Member 67

    6.8 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 68

    6.9 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 69

    6.10 Feb 25, 2016: Insulet Enters into Licensing Agreement with Mode AGC 72

    6.11 Feb 24, 2016: Ypsomed expands the distribution of mylife OmniPod in Europe 73

    6.12 Feb 24, 2016: Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results 73

    6.13 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 74

    6.14 Feb 02, 2016: Tandem Diabetes Care Expands Commercial Leadership 74

    6.15 Jan 29, 2016: Liberty Medical to Acquire Neighborhood Diabetes from Insulet for USD5 Million 75

    6.16 Jan 11, 2016: FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System For Use in Children 75

    6.17 Jan 11, 2016: Medtronic and Chengdu Sign Insulin Pump Manufacturing Agreement 76

    6.18 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 76

    6.19 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 77

    6.20 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 77

    6.21 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 78

    6.22 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 78

    6.23 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group of High-tech Enterprise 80

    6.24 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79 80

    6.25 Nov 17, 2015: Tandem Diabetes Care Announces Retirement of Board Chairman Lonnie Smith; Dick Allen Appointed as Successor Chairman 80

    6.26 Oct 29, 2015: Tandem Diabetes Care Reports Third Quarter 2015 Financial Results 81

    6.27 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results 82

    6.28 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 84

    6.29 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 85

    6.30 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC 85

    6.31 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 86

    6.32 Sep 01, 2015: MPSC New COO Appointment - Jason Zhang 89

    6.33 Aug 26, 2015: Greatbatch Partners with Wireless Power Leader WiTricity to Provide Wireless Charging for Medical Devices 89

    6.34 Aug 04, 2015: NICE draft guidance recommends integrated automatic glucose monitoring system for people with type 1 diabetes 90

    6.35 Aug 04, 2015: Animas Collaborates with Tidepool to Integrate Insulin Pump Data to Open-Source Software Aiding Diabetes Management 91

    6.36 Jul 30, 2015: Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 92

    6.37 Jul 30, 2015: Greatbatch Reports 2015 Second Quarter Results 92

    6.38 Jul 30, 2015: Tandem Diabetes Care Reports Second Quarter 2015 Financial Results 94

    6.39 Jul 24, 2015: Medtronic MiniMed Recalls MiniMed 620G and 640G Insulin Pumps 95

    6.40 Jun 19, 2015: cellnovo starts the expansion of its distribution network 95

    6.41 Jun 08, 2015: BD Medical Partners with Medtronic for Infusion Set 96

    6.42 Jun 08, 2015: Tandem Diabetes Care Announces t:simulator App Now Available for Android Devices 96

    6.43 Jun 05, 2015: Algostim to be Renamed Nuvectra 96

    6.44 Jun 03, 2015: Glooko Enters into Agreement with Dexcom 97

    6.45 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 97

    6.46 May 19, 2015: Tandem Diabetes Care Launches t:flex Insulin Pump 100

    6.47 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 100

    7 Appendix 104

    7.1 Methodology 104

    7.2 About GlobalData 106

    7.3 Contact Us 107

    7.4 Disclaimer 107

List Of Tables
in Insulin Pumps - Medical Devices Pipeline Assessment, 2016

1.1 List of Tables

Table 1: Insulin Pumps - Pipeline Products by Stage of Development 9

Table 2: Insulin Pumps - Pipeline Products by Segment 10

Table 3: Insulin Pumps - Pipeline Products by Territory 11

Table 4: Insulin Pumps - Pipeline Products by Regulatory Path 12

Table 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13

Table 6: Insulin Pumps - Ongoing Clinical Trials 14

Table 7: Insulin Pumps Companies - Pipeline Products by Stage of Development 15

Table 8: Insulin Pumps - Pipeline Products by Stage of Development 16

Table 9: Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17

Table 10: MEMS-based Insulin Pump - Product Status 18

Table 11: MEMS-based Insulin Pump - Product Description 18

Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 13: Gaia Med Diamond Insulin Pump - Product Status 19

Table 14: Gaia Med Diamond Insulin Pump - Product Description 19

Table 15: Gemini Pump - Product Status 20

Table 16: Gemini Pump - Product Description 20

Table 17: Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 18: Cellnovo Wireless Insulin Pump System - Product Status 22

Table 19: Cellnovo Wireless Insulin Pump System - Product Description 22

Table 20: Cellnovo Ltd. - Ongoing Clinical Trials Overview 23

Table 21: Cellnovo Wireless Insulin Pump System - Crossover Evaluation of Glycemic Control Provided for Three Days by the Artificial Pancreas Diabeloop Compared to Conventional Treatment by External Insulin Pump in Patients with Type 1 Diabetes in Sedentary Position, Outstanding Meals and Physical Activity: DIABELOOP WP6.2 24

Table 22: CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 25

Table 23: PaQ Insulin Delivery Device - Product Status 26

Table 24: PaQ Insulin Delivery Device - Product Description 26

Table 25: ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 26: Patch Pump - Product Status 27

Table 27: Patch Pump - Product Description 27

Table 28: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 29: Jewel Pump - Product Status 29

Table 30: Jewel Pump - Product Description 29

Table 31: JewelPUMP2 - Product Status 30

Table 32: JewelPUMP2 - Product Description 30

Table 33: Hospira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Table 34: Integrated Symbiq/EndoTool System - Product Status 32

Table 35: Integrated Symbiq/EndoTool System - Product Description 32

Table 36: Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 33

Table 37: OmniPod - Humalog U200 - Product Status 34

Table 38: OmniPod - Humalog U200 - Product Description 34

Table 39: OmniPod - New Version - Product Status 35

Table 40: OmniPod - New Version - Product Description 35

Table 41: InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36

Table 42: InsuPatch Device - Product Status 37

Table 43: InsuPatch Device - Product Description 37

Table 44: InsuLine Medical Ltd. - Ongoing Clinical Trials Overview 38

Table 45: InsuPatch Device - Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance 39

Table 46: LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 47: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status 41

Table 48: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description 41

Table 49: MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

Table 50: Freehand Patch Pump - Product Status 42

Table 51: Freehand Patch Pump - Product Description 42

Table 52: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 53: MiniMed 670G - Product Status 44

Table 54: MiniMed 670G - Product Description 44

Table 55: Medtronic plc - Ongoing Clinical Trials Overview 45

Table 56: MiniMed 670G - Multi-center, Randomized, Adaptive, Controlled Trial in Adult and Pediatric Patients with Type 1 Diabetes Using Hybrid Closed Loop System at Home 46

Table 57: MiniMed 670G - Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects with Type 1 Diabetes 46

Table 58: MiniMed 670G - Safety Evaluation of the Hybrid Closed Loop (HCL) System in Type 1 Diabetes 46

Table 59: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47

Table 60: Angel Touch - Product Status 48

Table 61: Angel Touch - Product Description 48

Table 62: La Fenice V - Product Status 49

Table 63: La Fenice V - Product Description 49

Table 64: NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

Table 65: FMA Patch - Diabetes Mellitus - Product Status 50

Table 66: FMA Patch - Diabetes Mellitus - Product Description 50

Table 67: Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 51

Table 68: Ambulatory Diabetes Pump - Product Status 51

Table 69: Ambulatory Diabetes Pump - Product Description 51

Table 70: Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 52

Table 71: SenseBolus - Product Status 53

Table 72: SenseBolus - Product Description 53

Table 73: SensePatch SD - Product Status 54

Table 74: SensePatch SD - Product Description 54

Table 75: SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 55

Table 76: Disposable Insulin Patch Pump - Product Status 55

Table 77: Disposable Insulin Patch Pump - Product Description 55

Table 78: Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56

Table 79: Spring Zone Hybrid Patch Pump - Product Status 56

Table 80: Spring Zone Hybrid Patch Pump - Product Description 56

Table 81: Tandem Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

Table 82: Next Generation t:slim Insulin Pump - Product Status 58

Table 83: Next Generation t:slim Insulin Pump - Product Description 58

Table 84: ViCentra B.V. Pipeline Products & Ongoing Clinical Trials Overview 59

Table 85: Kaleido Insulin Pump - Product Status 59

Table 86: Kaleido Insulin Pump - Product Description 59

Table 87: Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 60

Table 88: Lanzi - Product Status 61

Table 89: Lanzi - Product Description 61

Table 90: mylife YpsoPump - Next Version - Product Status 62

Table 91: mylife YpsoPump - Next Version - Product Description 62

Table 92: Glossary 105

List Of Figures, Charts and Diagrams
in Insulin Pumps - Medical Devices Pipeline Assessment, 2016

1.2 List of Figures

Figure 1: Insulin Pumps - Pipeline Products by Stage of Development 9

Figure 2: Insulin Pumps - Pipeline Products by Segment 10

Figure 3: Insulin Pumps - Pipeline Products by Territory 11

Figure 4: Insulin Pumps - Pipeline Products by Regulatory Path 12

Figure 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13

Figure 6: Insulin Pumps - Ongoing Clinical Trials 14

Additional Details

Publisher

Global Data

Publisher Information

Reference

26503 | GDME0181EPD

Number of Pages

107

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Latin America Infusion Pump Market by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), Setting (Hospital, Ambulatory Centers), Accessories - Forecast to 2021
The Latin American infusion pumps and accessories market is estimated to reach USD 671.9 million by ...
20 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Insulin Pumps - Medical Devices Pipeline Assessment, 2016
Insulin Pumps - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devices sector ...
09 May 2016 by Global Data USD $2,500 More Info
Insulin Pens - Medical Devices Pipeline Assessment, 2016
Insulin Pens - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devices sector r...
01 May 2016 by Global Data USD $2,500 More Info
Disposable Insulin Pumps - Medical Devices Pipeline Assessment, 2016
Disposable Insulin Pumps - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's Medical Devi...
01 Apr 2016 by Global Data USD $2,500 More Info
Infusion Pump Market - by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), by Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), by End User (Hospital, Home Care, Ambulatory Surgery Centers) - Global Forecast to 2020
The global infusion pumps and accessories market is expected to grow at a CAGR of 5.8% during the fo...
11 Jan 2016 by MarketsandMarkets USD $4,650 More Info
Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020
The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8...
04 Jan 2016 by MarketsandMarkets USD $4,650 More Info
Physician Views: The return of inhaled insulin – a paradigm shift or hard sell?
Scope Sanofi is currently in the process of launching Afrezza in the US market. Afrezza is an inhale...
13 Feb 2015 by FirstWord Pharma USD $695 More Info
Physician Views: What opportunity for biosimilar basal insulin?
Scope Two weeks ago, Sanofi significantly downgraded internal revenue projections for Lantus, its lo...
12 Nov 2014 by FirstWord Pharma USD $695 More Info
Physician Views: As MannKind's Afrezza nears approval, what opportunity for an inhaled insulin?
Scope MannKind's confirmation that the FDA has extended the PDUFA date for its inhaled insulin Afrez...
10 Apr 2014 by FirstWord Pharma USD $695 More Info
Physician Views – Sanofi's no-go decision on lixisenatide monotherapy sharpens focus on GLP-1/insulin combination products – what are the expectations of GPs, endocrinologists based in the US, 5EU?
ScopeA key dynamic of the highly competitive diabetes market is the relatively limited differentiati...
01 Sep 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Insulin Pumps - Medical Devices Pipeline Assessment, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...